|
|
|
Company Name
|
Santarus Inc.
|
|
Drug Name
|
UCERIS (NDA)
|
|
Event Name
|
FDA decision on UCERIS for induction of remission of mild to moderate active ulcerative colitis
|
|
Event Date
|
10/16/2012
|
|
Outcome
|
FDA extends UCERIS decision date to January 16, 2013
|
|
Drug Status
|
|
|
Rival Drugs
|
|
|
Market Potential
|
|
|
Other Approvals
|
|
|
News |
|
|
|
Return to FDA Calendar
|